BUILDING A NEW RESEARCH AND DEVELOPMENT LABORATORY OF QUINTA – ANALYTICA S.R.O. is co-financed by the European Union.

 

The aim of the project is to build a new research and development laboratory in Brno, which will significantly lead to the expansion of the existing research and innovation capacity (VIK). The project will create a top workplace equipped with the latest instruments and equipment for the analysis of medicinal products.

Project Name: Rozšíření výzkumné a vývojové kapacity společnosti QUINTA-ANALYTICA, s.r.o.

Project Number: CZ.01.1.02/0.0/0.0/20_338/0023928

EUROPEAN UNION

European Regional Development Fund

OP Enterprise and Innovation for Competitiveness

Additional News

  • 11 September 2025

    Meet us at CPHI 2025

    This October, the global pharmaceutical community will gather in Frankfurt for CPHI 2025. Quinta-Analytica as a member of Conscio Group will be there too – visit us in the Contract Manufacturing Hall 5.1, Stand F1.

  • 8 September 2025

    Quinta-Analytica successfully passed two onsite FDA inspections

    In the first half of 2025, Quinta-Analytica underwent two onsite inspections by the U.S. Food and Drug Administration (FDA).

  • 21 July 2025

    Boosting Bioanalytical Power for our clients

    New ICP-MS Expands Our Capabilities